ASCO GUIDELINES Bundle

NSCLC Stage IV with Driver Alterations

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475488

Contents of this Issue

Navigation

Page 17 of 17

Abbreviations ASCO, American Society of Clinical Oncolog y; EGFR, epidermal growth factor; NSCLC, non-small cell lung cancer; OH (CCO), Ontario Health (Cancer Care Ontario); TKI, tyrosine kinase inhibitor Source Singh N, Temin S, Baker, Jr. S, et al. erapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations Treatment: ASCO Guideline Update. J Clin Oncol. 2022 Jan 28. doi: 10.1200/JCO.22.00824 Hanna NH, et al. erapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. J Clin Oncol. 2021 Feb 16. doi: 10.1200/JCO.20.03570 e guideline was a cooperative effort among the American Society of Clinical Oncolog y and Ontario Health (Cancer Care Ontario). 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2022 All rights reserved ASCOLUND04222a Disclaimer is pocket guide is derived om recommendations in the American Society of Clinical Oncolog y Guideline. is resource is a practice tool based on ASCO ® practice guidelines and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. is pocket guide does not purport to suggest any particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. e practice guidelines and additional information are available at www.asco.org/ thoracic-cancer-guidelines. Copyright © 2022 by American Society of Clinical Oncolog y. All rights reserved. ASCO believes that cancer clinical trials are vital to inform medical decisions and improve cancer care and that all patients should have the opportunity to participate. Additional information, which may include data supplements, slide sets, and other clinical tools and resources, is available at www.asco.org/thoracic-cancer-guidelines.

Articles in this issue

Links on this page

Archives of this issue

view archives of ASCO GUIDELINES Bundle - NSCLC Stage IV with Driver Alterations